• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测子宫平滑肌肉瘤患者总生存期的列线图:一项基于 SEER 的人群研究。

A nomogram for predicting overall survival in patients with uterine leiomyosarcoma: a SEER population-based study.

机构信息

Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou 215006, PR China.

Department of Oncology, Jining Cancer Hospital, Jining, PR China.

出版信息

Future Oncol. 2020 Apr;16(10):573-584. doi: 10.2217/fon-2019-0674. Epub 2020 Mar 6.

DOI:10.2217/fon-2019-0674
PMID:32141309
Abstract

To establish and validate a nomogram for the estimation of overall survival of patients with uterine leiomyosarcoma (uLMS). Information on patients diagnosed as uLMS was retrospectively retrieved from the Surveillance, Epidemiology, and End Results database. The patients were randomly assigned into the training and the validation cohorts. Univariate and multivariate analyses were used to determine the independent prognostic factors for building a nomogram for predicting overall survival. The predictive accuracy was evaluated based on the concordance indices and the calibration plots. A nomogram that combined age, marital status, tumor size, Surveillance, Epidemiology, and End Result stage, surgery and radiation was established. The internal and external concordance indices were 0.748 and 0.745, respectively. The calibration plots approached 45 degrees. The nomogram might be an effective tool for predicting the survival of patients with uLMS.

摘要

建立并验证用于评估子宫平滑肌肉瘤(uLMS)患者总生存的列线图。从监测、流行病学和最终结果数据库中回顾性检索诊断为 uLMS 的患者信息。将患者随机分配到训练和验证队列中。使用单因素和多因素分析确定建立预测总生存的列线图的独立预后因素。基于一致性指数和校准图评估预测准确性。建立了一个结合年龄、婚姻状况、肿瘤大小、监测、流行病学和最终结果分期、手术和放疗的列线图。内部和外部一致性指数分别为 0.748 和 0.745。校准图接近 45 度。该列线图可能是预测 uLMS 患者生存的有效工具。

相似文献

1
A nomogram for predicting overall survival in patients with uterine leiomyosarcoma: a SEER population-based study.用于预测子宫平滑肌肉瘤患者总生存期的列线图:一项基于 SEER 的人群研究。
Future Oncol. 2020 Apr;16(10):573-584. doi: 10.2217/fon-2019-0674. Epub 2020 Mar 6.
2
External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma.子宫平滑肌肉瘤患者总生存预后列线图的外部验证。
Cancer. 2013 May 15;119(10):1816-22. doi: 10.1002/cncr.27971. Epub 2013 Mar 1.
3
Construction and Validation of Nomograms for Predicting the Prognosis of Uterine Leiomyosarcoma: A Population-Based Study.构建并验证预测子宫平滑肌肉瘤预后的列线图:基于人群的研究。
Med Sci Monit. 2020 Apr 9;26:e922739. doi: 10.12659/MSM.922739.
4
Prognostic nomogram for predicting the overall survival rate of patients with uterine clear-cell carcinoma: Based on SEER database.基于 SEER 数据库的预测子宫透明细胞癌患者总生存率的预后列线图
Int J Gynaecol Obstet. 2024 Aug;166(2):707-717. doi: 10.1002/ijgo.15456. Epub 2024 Mar 5.
5
Individualized evaluation of risk and prognosis in uterine leiomyosarcoma patients with synchronous distant metastases: a real-world retrospective study.子宫平滑肌肉瘤伴同步远处转移患者风险与预后的个体化评估:一项真实世界回顾性研究
Front Oncol. 2024 Sep 25;14:1417226. doi: 10.3389/fonc.2024.1417226. eCollection 2024.
6
A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma.用于预测子宫平滑肌肉瘤患者术后 5 年总生存率的列线图。
Cancer. 2012 Feb 1;118(3):660-9. doi: 10.1002/cncr.26333. Epub 2011 Jul 12.
7
Web-based nomograms for predicting overall survival and cancer-specific survival in retroperitoneal leiomyosarcoma: a population-based analysis.基于网络的后腹膜平滑肌肉瘤总生存和肿瘤特异性生存预测列线图:基于人群的分析。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11735-11748. doi: 10.1007/s00432-023-05052-y. Epub 2023 Jul 5.
8
Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?列线图能否预测软骨肉瘤患者的总生存和癌症特异性生存?
Clin Orthop Relat Res. 2018 May;476(5):987-996. doi: 10.1007/s11999.0000000000000152.
9
A novel nomogram for predicting cancer-specific survival in women with uterine sarcoma: a large population-based study.一种用于预测女性子宫肉瘤患者癌症特异性生存的新诺莫图:一项大型基于人群的研究。
BMC Womens Health. 2022 May 14;22(1):175. doi: 10.1186/s12905-022-01739-5.
10
Development, validation, and visualization of a web-based nomogram for predicting the incidence of leiomyosarcoma patients with distant metastasis.开发、验证和可视化一个基于网络的列线图,用于预测有远处转移的平滑肌肉瘤患者的发病风险。
Cancer Rep (Hoboken). 2022 May;5(5):e1594. doi: 10.1002/cnr2.1594. Epub 2021 Dec 3.

引用本文的文献

1
Individualized evaluation of risk and prognosis in uterine leiomyosarcoma patients with synchronous distant metastases: a real-world retrospective study.子宫平滑肌肉瘤伴同步远处转移患者风险与预后的个体化评估:一项真实世界回顾性研究
Front Oncol. 2024 Sep 25;14:1417226. doi: 10.3389/fonc.2024.1417226. eCollection 2024.
2
A bibliometric analysis of literatures on uterine leiomyosarcoma in the last 20 years.过去20年子宫平滑肌肉瘤文献的文献计量分析。
Front Oncol. 2024 Feb 12;14:1343533. doi: 10.3389/fonc.2024.1343533. eCollection 2024.
3
Nomogram predicting overall survival after surgical resection for retroperitoneal leiomyosarcoma patients.
用于预测腹膜后平滑肌肉瘤患者手术后总生存期的列线图。
Front Endocrinol (Lausanne). 2023 Jul 17;14:1160817. doi: 10.3389/fendo.2023.1160817. eCollection 2023.
4
Web-based nomogram to predict postresection risk of distant metastasis in patients with leiomyosarcoma: retrospective analysis of the SEER database and a Chinese cohort.基于网络的列线图预测平滑肌肉瘤患者术后远处转移风险:SEER 数据库和中国队列的回顾性分析。
J Int Med Res. 2023 Jul;51(7):3000605231188647. doi: 10.1177/03000605231188647.
5
Web-based nomograms for predicting overall survival and cancer-specific survival in retroperitoneal leiomyosarcoma: a population-based analysis.基于网络的后腹膜平滑肌肉瘤总生存和肿瘤特异性生存预测列线图:基于人群的分析。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11735-11748. doi: 10.1007/s00432-023-05052-y. Epub 2023 Jul 5.
6
A nomogram for predicting cancer-specific survival in patients with uterine clear cell carcinoma: a population-based study.基于人群的研究:用于预测子宫透明细胞癌患者癌症特异性生存的列线图。
Sci Rep. 2023 Jun 7;13(1):9231. doi: 10.1038/s41598-023-36323-w.
7
Clinical Analysis and Prognostic Prediction Model for Patients with Uterine Leiomyosarcoma at FIGO Stage I.国际妇产科联盟(FIGO)I期子宫平滑肌肉瘤患者的临床分析与预后预测模型
Int J Womens Health. 2023 Apr 11;15:545-557. doi: 10.2147/IJWH.S406381. eCollection 2023.
8
Development and validation of tumor-size-stratified prognostic nomograms for patients with uterine sarcoma: A SEER database analysis.基于 SEER 数据库的肿瘤大小分层预后列线图模型的建立及其对子宫肉瘤患者的预后预测价值
Cancer Med. 2023 Jan;12(2):1339-1349. doi: 10.1002/cam4.5014. Epub 2022 Jul 16.
9
A novel nomogram model to predict the overall survival of patients with retroperitoneal leiomyosarcoma: a large cohort retrospective study.一种新型列线图模型预测腹膜后平滑肌肉瘤患者的总生存期:一项大型队列回顾性研究。
Sci Rep. 2022 Jul 13;12(1):11851. doi: 10.1038/s41598-022-16055-z.
10
Prognosticators and Prognostic Nomograms for Leiomyosarcoma Patients With Metastasis.转移性平滑肌肉瘤患者的预后预测指标及预后列线图
Front Oncol. 2022 Mar 18;12:840962. doi: 10.3389/fonc.2022.840962. eCollection 2022.